
Astex Pharmaceutical takes 19 per cent stake in Mosaic Therapeutics
Mosaic Therapeutics has signed an in-licensing deal for two clinical-stage oncology programs from Astex Pharmaceuticals, a wholly owned subsidiary of Otsuka Pharmaceutical Co. Both companies are based in the Cambridge hub. Mosaic is a targeted oncology …